Literature DB >> 9127327

Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.

S Fletcher1, R G Jones, H C Rayner, P Harnden, L D Hordon, J E Aaron, B Oldroyd, A M Brownjohn, J H Turney, M A Smith.   

Abstract

Bone biopsies were studied in 73 patients to determine if a two-site radioimmunometric assay for serum bone alkaline phosphatase (BAP), total serum alkaline phosphatase (ALP), serum intact parathyroid hormone (iPTH), hand X-rays, regional bone mineral density (BMD) measurements and parathyroid enlargement detected by ultrasonography could accurately predict renal osteodystrophy. In the patients studied 57 had hyperparathyroid bone disease, 4 mixed renal osteodystrophy, 3 adynamic bone disease, 1 osteomalacia and 8 normal histology. Serum BAP, ALP and iPTH correlated positively with mineral apposition rate, osteoblastic, osteoid and eroded surface. In the diagnosis of hyperparathyroid bone disease serum iPTH was the most sensitive investigation, detecting 81% of patients at a level > 100 pg/ml but with a specificity of only 66%. Serum BAP was more sensitive, 70% at a level of > 10 ng/ml, than serum total ALP, 30% at a level of 300 IU/l, with similar specificities, 92 and 100%, respectively. Ultrasound detection of an enlarged parathyroid gland had a sensitivity of 64% and a specificity of 100% for the diagnosis of hyperparathyroid bone disease. Hand X-rays had a poor sensitivity, 47%, but a high specificity, 92%, for the detection of hyperparathyroid bone disease. The majority of patients had regional BMD values within the normal reference range and this test was of poor discriminatory value. The non-invasive markers were unable to distinguish between patients with low turnover, mild hyperparathyroidism and patients with normal histology. In conclusion the measurement of serum iPTH is a useful screening tool for the detection of hyperparathyroid bone disease which can be confirmed by the finding of a raised serum BAP or parathyroid enlargement. For definitive diagnosis, however, the gold standard remains bone biopsy and at present one cannot recommend any non-invasive method as an adequate substitute.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9127327     DOI: 10.1159/000189578

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  22 in total

1.  Biochemical indices of renal osteodystrophy in dialysis patients on the island of Malta.

Authors:  Ian Galea; Emanuel Farrugia
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 2.  Calcitriol resistance in hemodialysis patients with secondary hyperparathyroidism.

Authors:  Armando L Negri; Vincent M Brandenburg; Vincent M Brandemburg
Journal:  Int Urol Nephrol       Date:  2014-01-03       Impact factor: 2.370

3.  Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease.

Authors:  Sriharsha Damera; Kalani L Raphael; Bradley C Baird; Alfred K Cheung; Tom Greene; Srinivasan Beddhu
Journal:  Kidney Int       Date:  2010-09-29       Impact factor: 10.612

Review 4.  Low-trauma fractures without osteoporosis.

Authors:  E Lespessailles; B Cortet; E Legrand; P Guggenbuhl; C Roux
Journal:  Osteoporos Int       Date:  2017-02-04       Impact factor: 4.507

5.  Determinants of prevalent vertebral fractures and progressive bone loss in long-term hemodialysis patients.

Authors:  Jan Mares; Kristina Ohlidalova; Sylvie Opatrna; Jiri Ferda
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

6.  Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy.

Authors:  Syazrah Salam; Orla Gallagher; Fatma Gossiel; Margaret Paggiosi; Arif Khwaja; Richard Eastell
Journal:  J Am Soc Nephrol       Date:  2018-03-19       Impact factor: 10.121

7.  Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.

Authors:  Deborah L Regidor; Csaba P Kovesdy; Rajnish Mehrotra; Mehdi Rambod; Jennie Jing; Charles J McAllister; David Van Wyck; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 10.121

8.  Bone mineral density in live related kidney transplant children and adolescents.

Authors:  Amr A el-Husseini; Amgad E el-Agroudy; Ehab W Wafa; Tarek Mohsen; Mohamed A Sobh; Mohamed A Ghoneim
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 9.  Histomorphometric measurements of bone turnover, mineralization, and volume.

Authors:  Susan M Ott
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

10.  Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients.

Authors:  Konstantinos K Doumouchtsis; Alkis I Kostakis; Stergios K Doumouchtsis; Marios P Tziamalis; Charalambos P Stathakis; Evanthia Diamanti-Kandarakis; Dimitrios Dimitroulis; Despoina N Perrea
Journal:  J Bone Miner Metab       Date:  2008-01-10       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.